Foret-Lucas, C.; Figueroa, T.; Bertin, A.; Bessière, P.; Lucas, A.; Bergonnier, D.; Wasniewski, M.; Servat, A.; Tessier, A.; Lezoualc’h, F.;
et al. EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells. Viruses 2023, 15, 319.
https://doi.org/10.3390/v15020319
AMA Style
Foret-Lucas C, Figueroa T, Bertin A, Bessière P, Lucas A, Bergonnier D, Wasniewski M, Servat A, Tessier A, Lezoualc’h F,
et al. EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells. Viruses. 2023; 15(2):319.
https://doi.org/10.3390/v15020319
Chicago/Turabian Style
Foret-Lucas, Charlotte, Thomas Figueroa, Alexandre Bertin, Pierre Bessière, Alexandre Lucas, Dorian Bergonnier, Marine Wasniewski, Alexandre Servat, Arnaud Tessier, Frank Lezoualc’h,
and et al. 2023. "EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells" Viruses 15, no. 2: 319.
https://doi.org/10.3390/v15020319
APA Style
Foret-Lucas, C., Figueroa, T., Bertin, A., Bessière, P., Lucas, A., Bergonnier, D., Wasniewski, M., Servat, A., Tessier, A., Lezoualc’h, F., & Volmer, R.
(2023). EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells. Viruses, 15(2), 319.
https://doi.org/10.3390/v15020319